Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
BMJ Open
|
October 18, 2024
Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol
Krishna Tiwari, Surender Deora, Rahul Choudhary, et al.
Heart (British Cardiac Society)
|
November 25, 2022
Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study
Marcelo Martins Pinto-Filho, Gabriela Miana Paixão, Paulo Rodrigues Gomes, et al.
Global Heart
|
November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart
|
July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Nature Medicine
|
July 27, 2025
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial
Dorairaj Prabhakaran, Ambuj Roy, Ambalam M Chandrasekaran, et al.
The Lancet Regional Health. Southeast Asia
|
September 4, 2023
Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016-22
Pradeep Kumar Gunasekaran, Devika Shanmugasundaram, Sridhar Santhanam, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
BMJ Open
|
October 18, 2024
Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol
Krishna Tiwari, Surender Deora, Rahul Choudhary, et al.
Heart (British Cardiac Society)
|
November 25, 2022
Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study
Marcelo Martins Pinto-Filho, Gabriela Miana Paixão, Paulo Rodrigues Gomes, et al.
Global Heart
|
November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart
|
July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Nature Medicine
|
July 27, 2025
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial
Dorairaj Prabhakaran, Ambuj Roy, Ambalam M Chandrasekaran, et al.
The Lancet Regional Health. Southeast Asia
|
September 4, 2023
Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016-22
Pradeep Kumar Gunasekaran, Devika Shanmugasundaram, Sridhar Santhanam, et al.
Page
of 10